Roche Patents Blood Glucose Prediction System for Adverse Range Determination
Summary
The European Patent Office published patent application EP3651164A1, filed by Roche Diabetes Care GmbH, F. Hoffmann-La Roche AG, and mySugr GmbH. The patent covers methods and systems for determining the probability of a patient's blood glucose value falling within an adverse range at a specified prediction time. The patent is classified under G16H 50/20, 50/30, and 50/70 for health informatics diagnostics.
About this source
GovPing monitors EPO Patent Bulletin - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 45 changes logged to date.
What changed
The European Patent Office granted patent publication EP3651164A1 to Roche Diabetes Care GmbH, F. Hoffmann-La Roche AG, and mySugr GmbH for a computer-implemented method and system predicting adverse blood glucose events in diabetes patients. The patent covers algorithms that process patient data to calculate the probability of out-of-range blood glucose values at future timepoints.
Medical device manufacturers and digital health companies developing continuous glucose monitoring systems, insulin delivery algorithms, or diabetes management applications should review this patent landscape when designing predictive analytics features. The designated states span all EU member states plus several EEA and extension countries, giving the patent broad territorial coverage.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHOD AND SYSTEM OF DETERMINING A PROBABILITY OF A BLOOD GLUCOSE VALUE FOR A PATIENT BEING IN AN ADVERSE BLOOD GLUCOSE RANGE AT A PREDICTION TIME, AND COMPUTER PROGRAM PRODUCT
Publication EP3651164A1 Kind: A1 Apr 15, 2026
Applicants
Roche Diabetes Care GmbH, F. Hoffmann-La Roche AG, mySugr GmbH
Inventors
Duke, David L., Wrede, Jan, Bankosegger, Rafael
IPC Classifications
G16H 50/20 20180101AFI20260309BHEP G16H 50/30 20180101ALI20260309BHEP G16H 50/70 20180101ALI20260309BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.